OSCR
Income statement / Annual
Last year (2024), Oscar Health, Inc.'s total revenue was $9.18 B,
an increase of 56.54% from the previous year.
In 2024, Oscar Health, Inc.'s net income was $25.43 M.
See Oscar Health, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$9.18 B |
$5.86 B |
$4.13 B |
$1.92 B |
$589.64 M |
$553.78 M |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$9.18 B
|
$5.86 B
|
$4.13 B
|
$1.92 B
|
$589.64 M
|
$553.78 M
|
| Gross Profit Ratio |
1
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$1.76 B
|
$339.72 M
|
$309.78 M
|
$265.08 M
|
$166.66 M
|
$110.68 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.76 B
|
$339.72 M
|
$309.78 M
|
$265.08 M
|
$166.66 M
|
$110.68 M
|
| Other Expenses |
$7.36 B
|
$5.76 B
|
$4.24 B
|
-$2.76 B
|
-$1.16 B
|
-$924.93 M
|
| Operating Expenses |
$9.12 B
|
$6.10 B
|
$4.55 B
|
-$2.50 B
|
-$996.51 M
|
-$814.24 M
|
| Cost And Expenses |
$9.12 B
|
$6.10 B
|
$4.74 B
|
$2.49 B
|
$995.42 M
|
$813.17 M
|
| Interest Income |
$0.00
|
$0.00
|
$31.31 M
|
$10.25 M
|
$8.01 M
|
$11.12 M
|
| Interest Expense |
$23.73 M
|
$24.60 M
|
$22.62 M
|
$4.72 M
|
$3.51 M
|
$0.00
|
| Depreciation & Amortization |
$32.15 M
|
$30.69 M
|
$15.28 M
|
$14.61 M
|
$11.30 M
|
$6.90 M
|
| EBITDA |
$89.31 M |
-$212.00 M |
-$572.17 M |
-$551.26 M |
-$390.97 M |
-$252.49 M |
| EBITDA Ratio |
0.01
|
-0.04
|
-0.14
|
-0.29
|
-0.66
|
-0.46
|
| Operating Income Ratio |
0.01
|
-0.04
|
-0.14
|
-0.3
|
-0.69
|
-0.47
|
| Total Other Income/Expenses Net |
-$23.84 M
|
-$31.69 M
|
-$20.21 M
|
-$26.10 M
|
-$3.51 M
|
$0.00
|
| Income Before Tax |
$33.43 M
|
-$267.30 M
|
-$610.08 M
|
-$570.58 M
|
-$405.78 M
|
-$259.39 M
|
| Income Before Tax Ratio |
0
|
-0.05
|
-0.15
|
-0.3
|
-0.69
|
-0.47
|
| Income Tax Expense |
$7.31 M
|
$3.29 M
|
-$523,000.00
|
$846,000.00
|
$1.05 M
|
$1.79 M
|
| Net Income |
$25.43 M
|
-$270.73 M
|
-$609.55 M
|
-$571.43 M
|
-$406.83 M
|
-$261.18 M
|
| Net Income Ratio |
0
|
-0.05
|
-0.15
|
-0.3
|
-0.69
|
-0.47
|
| EPS |
0.11 |
-1.22 |
-2.87 |
-3.19 |
-1.7 |
-1.09 |
| EPS Diluted |
0.0957 |
-1.22 |
-2.87 |
-3.19 |
-1.7 |
-1.09 |
| Weighted Average Shares Out |
$240.39 M
|
$221.66 M
|
$212.47 M
|
$178.97 M
|
$239.31 M
|
$239.31 M
|
| Weighted Average Shares Out Diluted |
$265.85 M
|
$221.66 M
|
$212.47 M
|
$178.97 M
|
$239.31 M
|
$239.31 M
|
| Link |
|
|
|
|
|
|
